The Quant Field №05 LIVE
A working guide to systematic investing
Volume V · 2026
SPX +0.42% VIX -2.1% 10Y +3bp BTC +1.8% DXY -0.3%
Closed at 16:00 EST

The quant
field — α over σexcess.

The market is not random — but it is close. The Efficient Market Hypothesis is a useful lie. It is right enough that most strategies fail. It is wrong enough that some don't.

Every alpha you can earn lives in the cracks of that lie — the anomalies persistent enough to survive being widely known. Quant finance is the discipline of finding, measuring, and exploiting those cracks before everyone else does — and not fooling yourself in the process.

This guide is six interactive widgets across the canonical topics: how to measure a strategy, how to combine them, what your returns actually mean, the two archetypes of systematic alpha, the three ways your backtest is lying to you, and how big to bet.

VolumeV · 2026
Reading~ 25 minutes
Widgets6 · all playable
MathLight, honest
01The Game · Alpha
Efficient Market Hypothesis · Fama · 1970

The market is mostly right. That's why beating it pays.

Eugene Fama's Efficient Market Hypothesis says all available information is already in the price. If it were perfectly true, no one could ever earn excess return except by luck. It's not perfectly true — there are documented, persistent anomalies (value, momentum, size, quality, low-volatility) that have paid premiums for half a century. But it's true enough that most active managers, after fees, underperform the index. The job of the quant is to live in that 5% wedge between "completely efficient" and "wildly inefficient" — finding edges small enough that no one has bothered yet, durable enough to survive being known, and large enough to be worth implementing.
Three forms Weak (price history doesn't predict). Semi-strong (public info is priced in). Strong (even private info is priced in). Each is partially right.
Anomaly A return pattern not explained by risk. If you've found one, ask: why hasn't someone arbitraged it away yet? If you can't answer, it's already gone.
Trap "I have an edge" is the most expensive sentence in finance. Most edges are noise, fees in disguise, or risk you mispriced.
02The Measure
Sharpe Ratio · William Sharpe · 1966

Returns lie. Sharpe tells half the truth.

A strategy returning 50% sounds incredible — until you find it's 90% volatility and the path was harrowing. The Sharpe Ratio normalizes for risk: how much excess return are you getting per unit of volatility? An equity index sits around 0.4 long-term. Warren Buffett's lifetime number is roughly 0.75. Renaissance's Medallion is rumored to run 2–3 — and is closed to outside money for a reason. Above 2 in any backtest should make you suspicious. You may be measuring luck, hiding tail risk, or — most often — fooling yourself.
Rule Sharpe is the entry test, not the exit test. A strategy can have a great Sharpe and still blow up on the moves that don't fit a normal distribution.
Variant Sortino punishes only downside volatility. Calmar divides return by max drawdown. Use both alongside Sharpe.
Gotcha Sharpe assumes returns are normally distributed. They aren't. The kurtosis is where the funds die.
Move the sliders. See where you land.
Sharpe = (return − risk-free rate) / volatility · all annualized
12%
15%
4.0%
S&P 500 · long term~ 0.40
Bridgewater Pure Alpha~ 0.50
Berkshire Hathaway~ 0.75
Medallion Fund~ 2.50
YOUR STRATEGY
Sharpe Ratio0.53
(12%4%) / 15% = 0.53

Where you fall

poor
mediocre
good
great
00.51.01.52.0+
03The Free Lunch
Modern Portfolio Theory · Markowitz · 1952

Correlation, not count, is what diversifies.

Harry Markowitz won a Nobel for proving the only free lunch in finance: combining assets that aren't perfectly correlated lets you reduce portfolio risk without giving up expected return. The catch most people miss: it's not about owning more things, it's about owning differently correlated things. A portfolio of fifty tech stocks is less diversified than a portfolio of five well-chosen ones across uncorrelated regimes — equity, bonds, commodities, currencies, volatility. Slide the correlation below and watch the frontier curve flex; that curvature is the diversification benefit you're earning.
Math σ²p = w²Aσ²A + w²Bσ²B + 2wAwBρσAσB. The ρ term is the only place magic happens.
Insight At ρ < 1, portfolio σ is less than the weighted average of σA and σB. At ρ = -1, you can in theory build a zero-vol portfolio.
Trap Correlations are not constant. They spike toward +1 in crises — exactly when you needed them low. Stress-test your portfolio at ρ = 0.9 across the board.
Two assets · slide weight and correlation.
A = equity-like (μ 9% σ 16%) · B = bond-like (μ 4% σ 7%)
σ (annual vol) μ 0% 5% 10% 15% 20% 12% 9% 6% 3% A B
60%
0.20
Port. Return
7.0%
Port. Vol
11.5%
Sharpe (rf=4%)
0.26
Diversification benefit: at ρ = 0.20, your portfolio vol is below the weighted average of A and B's vol. That gap is the free lunch.
04The Decomposition
Fama-French + Carhart · 1993 / 1997

Most "alpha" is beta you didn't see.

A factor model decomposes returns into known risk premia plus true alpha. The Fama-French three-factor model adds size (small minus big) and value (high book-to-market minus low) to the market beta of CAPM. Carhart adds momentum. What's left after explaining your returns by these exposures is your actual edge. Run the decomposition on most "successful" managers and the alpha shrinks toward zero — they were earning a known premium and charging like it was secret sauce. The remaining alpha is rare, valuable, and worth paying for. Most "alpha" is just beta you didn't recognize.
Equation R − Rf = α + βM(RM−Rf) + βSMB·SMB + βHML·HML + βUMD·UMD + ε
Premia (historical, US, annual) Market: ~6% · Size (SMB): ~2% · Value (HML): ~3% · Momentum (UMD): ~7% · Quality (QMJ): ~4%
Reality Pre-2000 these premia were free money. Post-2010 most have shrunk or inverted. Factor crowding is real.
Pick a profile or build your own.
Loadings are exposures; α is what's left after factors explain your returns.

Profiles · click to load

0.0%
1.00
0.00
0.00
0.00

Return decomposition

Expected return (annual) 6.00%
Profile note: A pure market ETF earns the equity risk premium and nothing more. Zero alpha, zero factor tilts. The honest baseline.
05The Two
Mean Reversion vs Momentum · the bifurcation

Every strategy is one, or the other, or overfit.

Almost every systematic strategy reduces to one of two bets. Mean reversion says: prices that moved away from fair value will return. It works on short horizons and in calm, liquid markets. Momentum says: prices that have moved will keep moving. It works on longer horizons and in trending markets. They are not friends. A trending market punishes mean reversion; a choppy market punishes momentum. A strategy that profits in both regimes is either a real edge — or, much more often, an overfit. Below, the same synthetic price series under each regime, with each strategy's entries and exits.
Mean rev · works when Liquidity is high · spreads tight · macro stable · no regime shift in progress
Momentum · works when Macro shift or trend established · cross-sectional dispersion is high · risk-on or risk-off but committed
Failure mode Running mean-rev into a trend (you fade every rally to oblivion) · running momentum into a chop (you whipsaw out at every reversal)
One synthetic price. Two strategies. Two regimes.
Toggle the strategy and the market regime. Watch P&L diverge.
days price cumulative P&L
Total trades
Win rate
Total P&L
Sharpe
06The Mirage
The three classic backtesting sins

If your backtest looks too good, it is.

There are three classic ways to fool yourself with backtests, and every blown-up fund has done all three. Survivorship bias: you ran your strategy on the universe of stocks that still exist today, and the ones that went to zero quietly vanished from your dataset. Look-ahead bias: you used data at decision time that wouldn't have been available at decision time — earnings, restatements, classifications fixed in hindsight. Overfitting: you tuned 47 parameters until the strategy perfectly explained the past, with zero predictive power for the future. Each one independently can turn a real Sharpe of 0.0 into a backtest Sharpe of 2.5. Together, they're how everyone learns the same lesson the same way.
Cost Each sin inflates Sharpe by ~0.5–1.5. Stacked, a worthless strategy looks world-class until production, where it earns zero or less.
Defense · always Out-of-sample test, walk-forward analysis, point-in-time data, full universe (including delisteds), parameter stability check.
Pick a sin. See how it lies.
Each chart shows the backtest's illusion vs the live reality.
years value
"Survivors only" backtest Full universe (live)

Sin 01Survivorship Bias

Your backtest universe is today's surviving stocks. The ones that delisted, went to zero, or got acquired below cost silently disappear from your data.
Example
You backtest a "buy and hold the S&P 500" strategy from 2000 — using today's S&P 500. Enron, Lehman, Bear Stearns, WorldCom, Sears all dropped out. Your "S&P returns" are systematically too good.
Fix
Use point-in-time dataSource survivorship-bias-free datasets (CRSP for US equities). Always include delisted stocks. If you can't, knock 1–3% off your annualized return.
months cum P&L
Backtest with restated data Live (only what was known)

Sin 02Look-Ahead Bias

You use data at decision time that wouldn't have been available at decision time. Earnings restatements, GAAP changes, classification fixes — all backfilled by data vendors.
Example
Backtest a value strategy using "earnings" as published in today's database. Companies often restate earnings 3–18 months after the fact. Your strategy "knew" the restated number, real traders only had the original.
Fix
Point-in-time fundamentalsUse vintage data with as-of timestamps. Add a lag (T+1, T+3 trading days minimum) before acting on any fundamental. Assume you don't know it.
time return
True signal (none) 30-parameter "fit" Out-of-sample

Sin 03Overfitting

You tuned your strategy's parameters until it perfectly explained the past — and now it has zero predictive power for the future. The model memorized noise.
Example
A momentum strategy with 30 parameters across 5-year backtest data. In-sample Sharpe: 3.2. Out-of-sample: 0.1. The strategy fitted random noise — it had to, with that many degrees of freedom.
Fix
Fewer parameters · walk-forward · split sampleHold out 30% of the data, never touch it until the end. Use cross-validation. Penalize complexity (AIC/BIC). If >7 parameters, distrust the result.
07The Bet Size
Kelly Criterion · John Kelly · 1956

Picking the right side is half. Sizing it is the other half.

The Kelly Criterion says: bet a fraction of your bankroll proportional to your edge. Bet less, you grow slower. Bet more, you grow faster — until you over-bet, then you grow nowhere because variance eats you. Past 2× Kelly, you go to zero. The cruel truth is that most pros bet half-Kelly: half the long-term growth, but a fraction of the path-drawdown. Edge and sizing are independent skills. A trader with an edge of 5% who sizes wrong destroys more capital than a trader with no edge who never bets. Most public examples of "blown-up traders" are sizing failures, not edge failures.
Formula f* = p − (1−p)/b, where p = probability of win, b = win-to-loss payoff ratio.
Practical Use half-Kelly. Most edges are mis-estimated upward; full-Kelly on a real edge of 4% feels like full-Kelly on a phantom edge of 8%. Half = margin of safety.
Hard rule Negative Kelly (no edge) → don't bet. Some people fail this test. Don't be them.
Set your edge. Size accordingly.
f* = optimal fraction. The simulation shows why over-betting kills.
55%
1.0 : 1
200
Optimal bet (full Kelly)10.0%
f* = p − (1−p)/b = 0.55 − 0.45/1.00 = 0.10
Half-Kelly recommended. Real edges are mis-estimated. Halving gets you ~75% of the growth at ~25% of the drawdown risk.
Bankroll path · same edge, three sizings
bets → log $
Half Kelly Full Kelly 2× Kelly (over-bet)
Closing · three rules

The market is mostly right.
The rest is your job.

i. Measure honestly

Sharpe before stories. Drawdown before headlines.

A high return without a Sharpe is a story. A high Sharpe with an unstated max drawdown is half a story. Demand the full picture — from your strategy, from your manager, from yourself.

ii. Doubt the backtest

If it looks too good, it is.

The default state of any extraordinary backtest is overfit, biased, or both. Run out-of-sample. Walk forward. Strip parameters. If after all that it still looks great — be a little more suspicious, then act.

iii. Size as if you'll be wrong

Half-Kelly. Always.

Your edge is smaller than you think. Your drawdowns are bigger than your model. Bet for the next decade, not the next trade. The trader who survives compounding outearns the genius who blew up.